Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA
A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
New MND Early Diagnostic Test: a 'Game-Changer' for Research on the Disease
Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research
Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Speech-Analysis Tool for the Early Detection of Alzheimer's Handed to Linus Health in Acquisition
Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
Abcam: Cancer Biomarkers Guide
Merck: Analyte Quarterly
Meet Our Expert Speakers
Microbiome Drug Development Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Confirmed speakers include:
Amedeo Amedei
Professor,
University of Florence (Italy)
Bharat Dixit
CTO,
Adiso Therapeutics
Chrysi Sergaki
Microbiome Group Leader,
MHRA
Jonathan Swann
Professor of Biomolecular Medicine,
University of Southampton
Lesley Hoyles
Professor of Microbiome and Systems Biology,
Nottingham Trent University
Mona Bajaj
Associate Professor,
University College London
Robert Mills
Scientific Director,
Piton Therapeutics
Sanjib Bhakta
Professor of Molecular Microbiology and Biochemistry & Assistant Dean (Internationalisation and Partnership),
University College London